Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions
Open accessThe DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
Background: To inform policy and implementation that can enhance prevention and improve tuberculosis (TB) care cascade outcomes, this review aimed to summarize the impact of various interventions on care cascade outcomes for active TB. Methods and findings: In this systematic review and meta-analysis, we retrieved English articles with comparator arms (like randomized controlled trials (RCTs) and before and after intervention studies) that evaluated TB interventions published from January 1970 to September 30, 2022, from Embase, CINAHL, PubMed, and the Cochrane library. Commentaries, qualitative studies, conference abstracts, studies without standard of care comparator arms, and studies that did not report quantitative results for TB care cascade outcomes were excluded. Data from studies with similar comparator arms were pooled in a random effects model, and outcomes were reported as odds ratio (OR) with 95% confidence interval (CI) and number of studies (k). The quality of evidence was appraised using GRADE, and the study was registered on PROSPERO (CRD42018103331). Of 21,548 deduplicated studies, 144 eligible studies were included. Of 144 studies, 128 were from low/middle-income countries, 84 were RCTs, and 25 integrated TB and HIV care. Counselling and education was significantly associated with testing (OR = 8.82, 95% CI:1.71 to 45.43; I 2 = 99.9%, k = 7), diagnosis (OR = 1.44, 95% CI:1.08 to 1.92; I 2 = 97.6%, k = 9), linkage to care (OR = 3.10, 95% CI = 1.97 to 4.86; I 2 = 0%, k = 1), cure (OR = 2.08, 95% CI:1.11 to 3.88; I 2 = 76.7%, k = 4), treatment completion (OR = 1.48, 95% CI: 1.07 to 2.03; I 2 = 73.1%, k = 8), and treatment success (OR = 3.24, 95% CI: 1.88 to 5.55; I 2 = 75.9%, k = 5) outcomes compared to standard-of-care. Incentives, multisector collaborations, and community-based interventions were associated with at least three TB care cascade outcomes; digital interventions and mixed interventions were associated with an increased likelihood of two cascade outcomes each. These findings remained salient when studies were limited to RCTs only. Also, our study does not cover the entire care cascade as we did not measure gaps in pre-testing, pretreatment, and post-treatment outcomes (like loss to follow-up and TB recurrence). Conclusions: Among TB interventions, education and counseling, incentives, community-based interventions, and mixed interventions were associated with multiple active TB care cascade outcomes. However, cost-effectiveness and local-setting contexts should be considered when choosing such strategies due to their high heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous research has indicated that treatment adherence interventions (eg, patient counselling and education, reminders, and digital health technologies)47, 48 and social protection interventions (eg, cash transfers and economic incentives)49, 50 can increase treatment adherence and prevent mortality.”
From Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 (2024) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Self-citationWang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Armijo‐Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D., & Cummings, G. G. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01516.x · Cited by 1,539
Alipanah, N., Jarlsberg, L., Miller, C., Linh, N. N., Falzon, D., Jaramillo, E., & Nahid, P. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002595 · Cited by 503
Alsdurf, H., Hill, P. C., Matteelli, A., Getahun, H., & Menzies, D. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30216-x · Cited by 459
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Research works printed but not linked: 9
- World Health Organization, 2022, Tuberculosis: Key Facts.
- World Health Organization, The End TB Strategy
- W Wei, 2016, Impact of programmatic intervention on the treatment compliance of patients with HIV/TB dual infection., Int J Clin Exp Med, 9, 4173
- van’t Hoog A, editor. Sensitivity and specificity of different TB screening tools and approaches: a systematic review. 43rd Union World Conference on Lung Health, Kuala Lumpur, Malaysia; 2012.
- World Health Organization, Diagnostic testing for TB, HIV-associated TB and drug-resistant TB
- World Health Organization, Definitions and reporting framework for tuberculosis– 2013 revision (updated December 2014 and January 2020)
- S. Rajasekaran, 1993, Short course chemotherapy: A controlled study of indirect defaulter retrieval method., Indian J Tuberc, 40
- National Academies of Sciences, Engineering and Medicine, Health and Medicine Division, Board on Health Care Services, Board on Global Health, 2018, Committee on Improving the Quality of Health Care Globally. Crossing the Global Quality Chasm: Improving Health Care Worldwide, 4
- World Health Organization, WHO Consolidated Guidelines on Tuberculosis. Module 4: treatment—drug-resistant tuberculosis treatment
Cited by
Trajman, A., Campbell, J. R., Kunor, T., Ruslami, R., Amanullah, F., Behr, M. A., & Menzies, D. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02479-6 · Cited by 174
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00007-0 · Cited by 146
“…research has indicated that treatment adherence interventions (eg, patient counselling and education, reminders, and digital health technologies) 47,48 and social protection interventions (eg, cash transfers and economic incentives) 49,50 can increase treatment adherence and prevent mortality.”
Improving measurement of tuberculosis care cascades to enhance people-centred care
Faust, L., Naidoo, P., Caceres-Cardenas, G., Ugarte‐Gil, C., Muyoyeta, M., Kerkhoff, A. D., Nagarajan, K., Satyanarayana, S., Rakotosamimanana, N., Lapierre, S. G., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00375-4 · Cited by 29
Kebede, F., Bizuneh, T. K., Masresha, S. A., Kidie, A. A., Arage, M. W., Sirage, N., & Abate, B. B. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1386113 · Cited by 18
Izudi, J., Okello, G., & Bajunirwe, F. (2023) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2023.100375 · Cited by 12
Metadata
- Authors
- Marley, G., Zou, X., Nie, J., Cheng, W., Xie, Y., Liao, H., Wang, Y., Tao, Y., Tucker, J. D., Sylvia, S., Chou, R., Wu, D., Ong, J., & Tang, W.
- Affiliations
- Southern Medical University (CN)
- Guangdong Academy of Medical Sciences (CN)
- City University of Hong Kong (HK)
- London School of Hygiene & Tropical Medicine (GB)
- University of North Carolina at Chapel Hill (US)
- Oregon Health & Science University (US)
- Monash University (AU)
- Corresponding author
- Tang, Weiming
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2023-01-03
- Volume
- 20
- Issue
- 1
- Pages
- e1004091
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC9847969
- OpenAlex
- W4313453183
- Cited by
- 28
- References
- 129
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 9 · 2023: 2
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Update notices
- new_version (2023-01-18)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- CityU Scholars (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Health (R34MH119963)
- Key Technologies Research and Development Program (2022YFC2304900-04)
- National Nature Science Fundation of China (81903371)
- CRDF Global (G-202104-67775)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculosis, cascade of care, active tuberculosis, tuberculosis diagnosis, linkage to care, treatment completion, treatment success, low- and middle-income countries, tuberculosis prevention, health system performance, healthcare workers, health care financing, health policy, health system strengthening
- MeSH terms
- Counseling, Humans, Motivation, Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions. https://app.cochat.ai/papers/10.1371/journal.pmed.1004091
- The paper
- Marley, G., Zou, X., Nie, J., Cheng, W., Xie, Y., Liao, H., Wang, Y., Tao, Y., Tucker, J. D., Sylvia, S., Chou, R., Wu, D., Ong, J., & Tang, W. (2023). Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.